PRESS RELEASE published on 01/25/2024 at 15:00, 2 years 2 months ago Jim Ellis Automotive Donates $75K to Help End Hunger in Metro Atlanta Communities Jim Ellis Automotive Group's annual Holiday Giving Campaign concluded with a $75,000 donation to the Atlanta Community Food Bank, providing around 225,000 meals for neighbors in need. The campaign, which ran between Nov. 24, 2023, and Jan. 2, 2024, is part of the group's ongoing commitment to supporting local charities. With nearly 700 community-based nonprofit partners, the Atlanta Community Food Bank distributes approximately 9 million meals monthly across metro Atlanta and North Georgia. Jim Ellis Automotive Group Holiday Giving Campaign Atlanta Community Food Bank Hunger Relief Charitable Donation
PRESS RELEASE published on 01/25/2024 at 14:50, 2 years 2 months ago PodcastOne Renews Agreement with The Adam Carolla Podcast and The Adam and Dr. Drew Show PodcastOne renews its agreement with Adam Carolla for The Adam Carolla Podcast and The Adam and Dr. Drew Show, celebrating over 700 million downloads and Carolla's induction into the Podcast Hall of Fame during the 2024 Podfest Expo. The announcement highlights Carolla's significant contributions to podcasting and the continued growth and development of PodcastOne as a leading podcast platform. PodcastOne Adam Carolla Podfest Expo Podcasting Industry Digital Audio Entertainment
PRESS RELEASE published on 01/25/2024 at 14:33, 2 years 2 months ago Splash Beverage Group's Copa di Vino Now Available in Save Mart Stores Throughout California Splash Beverage Group, Inc. announced that its Copa Di Vino and Pulpoloco Sangria will now be available in 200 Save Mart Stores located in Central and Northern California. The planogram positions for these products have already been provided, with on-shelf availability starting in February. This expansion is part of Splash Beverage Group's strategy to rapidly develop and accelerate its brand portfolio and global distribution. For more information, visit www.SplashBeverageGroup.com. Splash Beverage Group Copa Di Vino Pulpoloco Sangria Save Mart Stores Beverage Brands
PRESS RELEASE published on 01/25/2024 at 14:33, 2 years 2 months ago KYN Capital Group Releases New Version of Koinfold 2.0 on Google Play Store and Submits the Apple IOS Version for Release KYN Capital Group has released a new version of Koinfold 2.0 on the Google Play Store and has submitted the Apple IOS version for release. The updated version includes new features such as cryptocurrency swap options, email verification for security, and 24/7 cryptocurrency news. Koinfold 2.0 also offers the ability to mine crypto through Cudominer and a user-friendly design. The 'Learn to Earn' feature allows users to test the market with $10,000 in play cryptocurrency, providing a safe and easy way to learn. The app will soon implement a precious metal feature, which is expected to generate substantial revenue for KYN Capital Group. CEO Rick Wilson expressed optimism about the alignment of Koinfold with the crypto movement and its potential to generate significant revenue. For more information, follow KYN Capital Group, Inc. (KYNC) on Twitter and visit their website. KYN Capital Group Koinfold 2.0 Cryptocurrency Swap Apple IOS Version Precious Metal Feature
PRESS RELEASE published on 01/25/2024 at 14:30, 2 years 2 months ago Dog Study Published in PLOS ONE Shows Statistically Significant Results for Use of Jaguar Health’s Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea (CTD) Jaguar Health, Inc. (NASDAQ:JAGX) has announced the publication of a study evaluating the effects of crofelemer in providing symptomatic relief of diarrhea associated with the irreversible pan-human epidermal growth factor receptor (HER) tyrosine kinase inhibitor neratinib (Nerlynx®) in female dogs. The study, conducted by Napo Pharmaceuticals in collaboration with Puma Biotechnology, highlights the growing need for treatment of cancer therapy-related diarrhea (CTD), a common and debilitating side effect of patients undergoing cancer therapy. The findings of this study, along with two other important studies, provide scientific rationale for the use of crofelemer in humans for the prevention and treatment of CTD, addressing the unmet medical need in the age of targeted cancer therapies. Napo Pharmaceuticals Crofelemer Jaguar Health Inc Neratinib Cancer Therapy-related Diarrhea
PRESS RELEASE published on 01/25/2024 at 14:15, 2 years 2 months ago Revolutionizing NDT Inspection: Voliro's Innovative Technology Eliminates Downtime Voliro introduces the high-temperature Ultrasonic Testing (UT) payload for the Voliro T drone, revolutionizing the Non-Destructive Testing (NDT) sector by enabling inspections on hot surfaces without costly downtime. This groundbreaking technology offers a safer, more efficient, and cost-effective approach to inspections in challenging industrial environments. Voliro T Drone High-temperature UT Payload Non-Destructive Testing Drone-based Inspections Industrial Applications
PRESS RELEASE published on 01/25/2024 at 14:15, 2 years 2 months ago FAVO Capital, Inc. Opens A Second Call Centre Location in Dominican Republic and Continues to Implement its Growth Strategy FAVO Capital Inc., a respected alternate finance company, is expanding its reach with the opening of a new call centre location in the Dominican Republic. This strategic move showcases its commitment to providing exceptional financial solutions and services, offering innovative products, and investing in technology and talent to meet the needs of its clientele. The company is also dedicated to community engagement, aiming to make a positive impact beyond financial services. With this expansion, FAVO Capital reinforces its position as a leader in the industry and invites clients, partners, and the media to stay updated on their journey towards innovation and excellence. Financial Solutions Community Engagement FAVO Capital Inc. Alternate Finance Company Call Centre Expansion
PRESS RELEASE published on 01/25/2024 at 14:07, 2 years 2 months ago CMI Investor Alert: Kaplan Fox Investigates Potential Securities Fraud At Cummins, Inc. Kaplan Fox & Kilsheimer LLP is conducting an investigation into potential securities fraud at Cummins Inc. following the announcement of a $1.675 billion penalty to settle claims of violating the Clean Air Act. If you are an investor of Cummins Inc. and would like to discuss the investigation, contact Kaplan Fox for more information. With over 50 years of experience in securities litigation, Kaplan Fox is a leading national law firm with a track record of successfully shaping the law through winning important decisions on behalf of clients. Cummins Inc. Securities Fraud Kaplan Fox Clean Air Act Investigation
PRESS RELEASE published on 01/25/2024 at 14:05, 2 years 2 months ago Louisiana, USA: Cloud-based deployment of Kapsch’s Commercial Back Office System and End-to-End tolling solution enters full operation Kapsch TrafficCom successfully deploys a cloud-based Commercial Back Office System and End-to-End tolling solution in Louisiana, USA. The LA1 tolling facility, serving as a crucial transportation artery for the state and country, has been revamped with state-of-the-art toll collection and enhanced customer service capabilities. Kapsch TrafficCom Commercial Back Office System End-to-End Tolling Solution LA1 Tolling Facility Louisiana
PRESS RELEASE published on 01/25/2024 at 14:03, 2 years 2 months ago BioAdaptives' Subsidiary, Livestock Impact, Inc., Celebrates Banner 2023 Equine Championship Titles Attributed to Its Advanced Proprietary Supplement Products BioAdaptives Inc. celebrates the achievement of multiple Equine Championship Titles attributed to its subsidiary Livestock Impact, Inc.'s advanced proprietary supplements. The highlight was the spectacular performance of Cheyanne Colclasure with her 23-year-old horse, Docs Dual Quixote, who secured the 35,000 Non Pro National Championship Title at the 2023 United States Cutting Horse Association (USCHA) National Championship competition. Livestock Impact's All-In-One supplement formulas have shown rejuvenating effects such as improved energy, agility, and response time in animals. BioAdaptives, Inc. manufactures and distributes natural plant- and algal-based products that improve health and wellness for humans and animals, with an emphasis on pain relief, antiviral activity, immune system defense, resistance to stress, endurance, recovery, and anti-aging properties. The company's products for horses and dogs provide general health, competitive performance enhancement, rejuvenation effects, and pain relief, as well as improvements in appearance. BioAdaptives Inc. Livestock Impact Equine Championship Titles Proprietary Supplements All-natural Dietary Supplements
Published on 04/17/2026 at 15:15, 1 hour 1 minute ago Loar Holdings Inc. Announces Date and Time for First Quarter 2026 Earnings and Conference Call
Published on 04/17/2026 at 15:00, 1 hour 16 minutes ago Karbon-X Launches SkyXero, a New App for Flight Emissions Tracking as Travelers Seek Trusted Climate Solutions
Published on 04/17/2026 at 14:50, 1 hour 26 minutes ago Nepra Foods Announces Chadwick White's Participation in the 2026 American Bakers Association Annual Convention
Published on 04/17/2026 at 13:35, 2 hours 41 minutes ago Silver X Mining Corp. Announces Appointment of Mark NJ Ashcroft to Board of Directors
Published on 04/17/2026 at 13:00, 3 hours 16 minutes ago Meta Critical Minerals Announces Completion of Over Subscribed Private Placement With Strategic Advisory Support From Leading New York Investment Bank Revere Securities
Published on 04/17/2026 at 15:35, 41 minutes ago SNP reports best Q1 ever after three consecutive record years
Published on 04/17/2026 at 15:32, 43 minutes ago Form 8.3 - The Vanguard Group, Inc.: A consortium comprising LondonMetric Property plc and Schroder Real Estate Investment Trust Limited
Published on 04/17/2026 at 15:31, 44 minutes ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
Published on 04/17/2026 at 15:26, 50 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of March 31, 2026
Published on 04/17/2026 at 15:26, 50 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 mars 2026
Published on 04/17/2026 at 09:10, 7 hours 6 minutes ago Nombre total d'actions et droits de vote - mars 2026
Published on 04/17/2026 at 09:10, 7 hours 6 minutes ago Number of shares and voting rights - March 2026 (In French only)
Published on 04/16/2026 at 18:02, 22 hours 14 minutes ago Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026